| Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC (NCT06127303) | Shanghai Chest Hospital | 2024-04-02 |
| Beetroot Juice NO Cold Study (NCT06416228) | Southern Methodist University | 2024-04-02 |
| A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults (NCT06375772) | G.ST Antivirals GmbH | 2024-04-02 |
| A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer (NCT06283121) | China Medical University, China | 2024-04-02 |
| Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis (NCT06319794) | TORQUR | 2024-04-02 |
| Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer (NCT06241781) | Grit Biotechnology | 2024-04-02 |
| Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL (NCT06387121) | Institute of Hematology & Blood Diseases Hospital, China | 2024-04-02 |
| Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH (NCT05937854) | VA Office of Research and Development | 2024-04-01 |
| Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH) (NCT07293468) | Tuen Mun Hospital | 2024-04-01 |
| First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC (NCT06370663) | Shandong Cancer Hospital and Institute | 2024-04-01 |
| Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma (NCT06327451) | Tianjin Medical University General Hospital | 2024-04-01 |
| Maintenance Hormonal Therapy and DLBCL (NCT06355401) | Sohag University | 2024-04-01 |
| Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC (NCT06300424) | Guangdong Provincial People's Hospital | 2024-04-01 |
| Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma (NCT06646588) | Hebei Medical University Fourth Hospital | 2024-04-01 |
| Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART (NCT05668026) | University of Aarhus | 2024-04-01 |
| Nutritional Therapy in Late-onset Pompe Disease (NCT06130228) | McMaster University | 2024-04-01 |
| Intravenous Labetalol Versus Hydralazine in Preeclampsia (NCT06360601) | Tanta University | 2024-04-01 |
| Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration) (NCT06367114) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2024-04-01 |
| The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation (NCT06348849) | Alexandria University | 2024-04-01 |
| VA vs DA for Newly Diagnosed Hig-risk AML (NCT05939180) | The First Affiliated Hospital of Soochow University | 2024-04-01 |
| A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma (NCT07075328) | Otsuka Medical Devices Co., Ltd. Japan | 2024-04-01 |
| Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer (NCT06192680) | Harbin Medical University | 2024-04-01 |
| High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases (NCT06319950) | Taizhou Hospital | 2024-04-01 |
| Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy (NCT06332950) | Baohui Han | 2024-04-01 |
| ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) (NCT06342947) | Aligos Therapeutics | 2024-04-01 |
| Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (NCT06315972) | LMU Klinikum | 2024-04-01 |
| Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma (NCT06383728) | The First Affiliated Hospital of Guangzhou Medical University | 2024-04-01 |
| Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM (NCT06341595) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-01 |
| Role of Intralipid in Management of Organophosphorus Poisoning (NCT04393103) | Amani Hassan Abdel-Wahab | 2024-04-01 |
| A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer (NCT06023277) | Jacinto Convit World Organization Inc. | 2024-04-01 |
| Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer (NCT05810792) | Sahlgrenska University Hospital | 2024-04-01 |
| Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation. (NCT06327399) | Kasr El Aini Hospital | 2024-04-01 |
| Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase (NCT07555678) | Fudan University | 2024-04-01 |
| Fascia Transversalis Versus Transversus Abdominis Plane Block for Children Undergoing Inguinal Hernia Surgery (NCT06326944) | Kasr El Aini Hospital | 2024-04-01 |
| Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors (NCT07059832) | First Hospital of China Medical University | 2024-04-01 |
| Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer (NCT06304987) | Beijing Friendship Hospital | 2024-04-01 |
| Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) (NCT06387056) | The First Affiliated Hospital of Xiamen University | 2024-04-01 |
| Efficacy of Hyaluronic Acid in Prevention of Acute Radiation Proctitis (NCT06469216) | Assiut University | 2024-04-01 |
| A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population (NCT05708235) | MedSIR | 2024-04-01 |
| Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases (NCT06356584) | Shandong Cancer Hospital and Institute | 2024-04-01 |
| A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia (NCT05688839) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-04-01 |
| Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa (NCT06492850) | Frontera Therapeutics | 2024-04-01 |
| Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis (NCT06391164) | PHARMENTERPRISES LLC | 2024-04-01 |
| Interventional Software for Multi-immunotherapy of Solid Tumors (NCT06478108) | Second Affiliated Hospital of Guangzhou Medical University | 2024-04-01 |
| Low Level Diode Laser Versus Topical Chamomile in Management of Chemotherapy Induced Oral Mucositis (NCT06214273) | Cairo University | 2024-04-01 |
| This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity (NCT06857617) | Metsera, a wholly owned subsidiary of Pfizer | 2024-04-01 |
| Ladarixin With Sotorasib in Advanced NSCLC - Phase II (NCT05815186) | NYU Langone Health | 2024-04-01 |
| ADI-PEG20, Obesity and Prediabetes (NCT05829239) | Washington University School of Medicine | 2024-04-01 |
| A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion (NCT06158854) | AbbVie | 2024-04-01 |
| A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) (NCT06181591) | Seoul National University Hospital | 2024-04-01 |
| mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy (NCT06249321) | Fudan University | 2024-04-01 |
| Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD (NCT05959434) | Texas A&M University | 2024-04-01 |
| Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia (NCT06034561) | Instituto do Cancer do Estado de São Paulo | 2024-04-01 |
| 3-Month Clinical Trial of Liquid S-PRF in Periodontal Debridement for Periodontitis Stages II-IV (NCT07293962) | Mahsa University | 2024-04-01 |
| Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms (NCT04629651) | Case Comprehensive Cancer Center | 2024-04-01 |
| Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore (NCT06202716) | Nanfang Hospital, Southern Medical University | 2024-04-01 |
| Balloon Pulmonary Angioplasty vs. Combined Approach With Pulmonary Artery Denervation in CTEPH: Effectiveness Comparison (NCT06209710) | Boris Dzudovic | 2024-04-01 |
| Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) (NCT06069375) | Jerry Vockley, MD, PhD | 2024-04-01 |
| Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO (NCT06792643) | IRCCS San Raffaele | 2024-04-01 |
| Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma (NCT06749730) | Henan Cancer Hospital | 2024-04-01 |
| Effect of Belimumab on Antibody Titers in Primary APS Patients (NCT06747312) | Ruijin Hospital | 2024-04-01 |
| Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer (NCT06259058) | Tianjin Medical University Cancer Institute and Hospital | 2024-04-01 |
| Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor (NCT06302023) | Khon Kaen University | 2024-04-01 |
| Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC (NCT07359404) | YING FAN | 2024-04-01 |
| SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19) (NCT06288893) | JKT Biopharma Co., Ltd. | 2024-04-01 |
| A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo (NCT06131372) | Novo Nordisk A/S | 2024-04-01 |
| A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation (NCT05745740) | RemeGen Co., Ltd. | 2024-04-01 |
| Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial (NCT06256237) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-04-01 |
| Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer (NCT06360978) | Assiut University | 2024-04-01 |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head (NCT05637567) | German Cancer Research Center | 2024-04-01 |
| Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 (NCT06071767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-04-01 |
| Metformin and Lactoferrin in Sepsis in Icu (NCT06181422) | Tanta University | 2024-04-01 |
| Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) (NCT05983471) | Melius Pharma AB | 2024-04-01 |
| Comparison of Effects of Fenofibrate Adjuvant Therapy Versus Conventional Phototherapy in Neonatal Jaundice. (NCT06346743) | Muhammad Zark | 2024-04-01 |
| Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer (NCT06525428) | Fudan University | 2024-04-01 |
| Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients (NCT06301386) | Fudan University | 2024-04-01 |
| A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011 (NCT06354114) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2024-04-01 |
| Efficacy and Safety of a Hydrogel Containing Cascade Catalytic Enzymes in the Treatment of Diabetic Wounds (NCT06492811) | The First Affiliated Hospital of University of South China | 2024-04-01 |
| N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer (NCT05445882) | National Cancer Institute (NCI) | 2024-04-01 |
| Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke (NCT06653348) | Mazandaran University of Medical Sciences | 2024-04-01 |
| An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia (NCT05686629) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-04-01 |
| Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer (NCT06430658) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-04-01 |
| Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC (NCT06379399) | Wangxia LV | 2024-04-01 |
| A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (NCT06323928) | H. Lundbeck A/S | 2024-04-01 |
| Perforating Cutaneous Nerve Injection Efficacy in Chronic Coccydynia: A Randomized, Double-Blind Study (NCT06315244) | Sisli Hamidiye Etfal Training and Research Hospital | 2024-04-01 |
| A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection (NCT06016088) | Respirion Pharmaceuticals Pty Ltd | 2024-04-01 |
| A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors (NCT06265727) | Corbus Pharmaceuticals Inc. | 2024-04-01 |
| Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC (NCT06238167) | First Affiliated Hospital of Wenzhou Medical University | 2024-04-01 |
| Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . (NCT05927857) | National Health Research Institutes, Taiwan | 2024-04-01 |
| Optimizing Reversal of HIV Latency With Combination Therapy (NCT06240520) | Erasmus Medical Center | 2024-04-01 |
| Clemastine Treatment in Individuals With Williams Syndrome (NCT06087757) | Sheba Medical Center | 2024-04-01 |
| Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC (NCT06322563) | Tianjin Medical University Cancer Institute and Hospital | 2024-04-01 |
| DEC-C and Thioguanine for R/R AML (NCT06351306) | Columbia University | 2024-04-01 |
| Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer (NCT06462053) | Fudan University | 2024-04-01 |
| Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC) (NCT06320301) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-04-01 |
| Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection (NCT06276504) | Assistance Publique - Hôpitaux de Paris | 2024-04-01 |
| A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma (NCT06368167) | Jiangsu HengRui Medicine Co., Ltd. | 2024-04-01 |
| A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above (NCT06361875) | Sanofi Pasteur, a Sanofi Company | 2024-04-01 |
| Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer (NCT07646145) | Shanxi Province Cancer Hospital | 2024-04-01 |
| Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma (NCT06988956) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-31 |